Market news
PARSIPPANY, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events: Wells Fargo 2026 Healthcare ConferenceManagement will host one-on-one investor meetings on Wednesday, September 9, 2026, at the Encore Boston Harbor Hotel in Everett, Boston, MA.J.P. Morgan 4th Annu
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
Embecta (EMBC) stock jumps after a big earnings beat and raised FY2026 guidance.
GlobeNewswire Press Release.
Moby summary of Embecta Corp.'s Q3 2026 earnings call
PARSIPPANY, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported third quarter fiscal 2026 financial results. Visit the company’s Investor Relations website at http://investors.embecta.com to view the detailed third quarter fiscal 2026 earnings press release and investor presentation. The company will host a conference call and l
PARSIPPANY, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.01 for each issued and outstanding share of the Company’s common stock. The dividend is payable on September 15, 2026 to stockholders of record at the close of business on August 27, 2026.About embectaembecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company,
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
PARSIPPANY, N.J., July 23, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal third quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, August 7, 2026. Those who would like to participate may access the live webcast
Detailed price information for Embecta Corp (EMBC-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.